TECH - How Are Obesity Drugs And Nvidia Related? Success Of Ozempic Wegovy Propels Novo Nordisk Foundation To Fund Nvidia-Powered AI Supercomputer For Faster Drug Development | Benzinga
Novo Nordisk A/S (NYSE:NVO), the maker of popular diabetes and weight loss drugs like Ozempic and Wegovy, is delving into artificial intelligence.
Backed by the Novo Nordisk Foundation, Eviden, a French computing company, is set to construct a supercomputer leveraging Nvidia Corp’s (NASDAQ:NVDA) AI technology.
Cédric Bourrasset, Eviden’s quantum computing chief, anticipates the supercomputer, dubbed Gefion, will revolutionize drug discovery and healthcare solutions, offering speed and efficiency.
Expected to commence pilot projects by year-end, Gefion will be stationed at Denmark’s newly established ...